4911 — Shiseido Co Balance Sheet
0.000.00%
- ¥946bn
- ¥1tn
- ¥991bn
Annual balance sheet for Shiseido Co, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 151,013 | 172,932 | 137,534 | 126,641 | 126,861 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 141,084 | 158,791 | 182,069 | 149,688 | 154,305 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 514,763 | 512,922 | 524,229 | 470,014 | 477,800 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 341,044 | 467,869 | 432,615 | 402,386 | 399,287 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 1,204,229 | 1,300,979 | 1,307,661 | 1,255,497 | 1,331,848 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 352,977 | 413,561 | 389,562 | 368,345 | 398,562 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 718,541 | 760,284 | 703,401 | 636,749 | 699,374 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 485,688 | 540,695 | 604,260 | 618,748 | 632,474 |
Total Liabilities & Shareholders' Equity | 1,204,229 | 1,300,979 | 1,307,661 | 1,255,497 | 1,331,848 |
Total Common Shares Outstanding |